VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017 03 09; 129(10):1275-1283.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Aminoglycosides
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Arsenicals
Disease-Free Survival
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Leukemia, Promyelocytic, Acute
Male
Middle Aged
Oxides
Polymerase Chain Reaction
Treatment Outcome
Tretinoin
Young Adult
authors with profiles
MICHAEL ANDREEFF
RAJYALAKSHMI LUTHRA
STEVEN M KORNBLAU
ZEEV ESTROV
MARINA KONOPLEVA
ALESSANDRA FERRAJOLI
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO
WILLIAM G WIERDA
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
NITIN JAIN
NAVAL DAVER
COURTNEY DINARDO
HAGOP M KANTARJIAN